BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 15888405)

  • 1. The impact of menstrual side effects on contraceptive discontinuation: findings from a longitudinal study in Cairo, Egypt.
    Tolley E; Loza S; Kafafi L; Cummings S
    Int Fam Plan Perspect; 2005 Mar; 31(1):15-23. PubMed ID: 15888405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives.
    Modesto W; Bahamondes MV; Bahamondes L
    Hum Reprod; 2014 Jul; 29(7):1393-9. PubMed ID: 24812309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acceptability study of the two versus three monthly injectable contraceptives.
    Aly FA; El-genedi MM; Toppozada HK; El-abd M; Loutfi I
    Dirasat Sukkaniyah; 1984; 11(69):27-39. PubMed ID: 12179796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaginal bleeding patterns in women using once-a-month injectable contraceptives.
    Fraser IS
    Contraception; 1994 Apr; 49(4):399-420. PubMed ID: 8013222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implanon users are less likely to be satisfied with their contraception after 6 months than IUD users.
    Wong RC; Bell RJ; Thunuguntla K; McNamee K; Vollenhoven B
    Contraception; 2009 Nov; 80(5):452-6. PubMed ID: 19835719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What are the prospects for the hormonal IUD in the public sector? A mixed-method study of the user population in Zambia.
    Brunie A; Lydon M; Stankevitz K; Chintu N; Brennan C; Danna K; Rademacher KH
    BMC Womens Health; 2022 May; 22(1):178. PubMed ID: 35570281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaginal bleeding patterns of women using different contraceptive methods (implants, injectables, IUDs, oral pills)--an Indian experience. An ICMR Task Force Study. Indian Council of Medical Research.
    Datey S; Gaur LN; Saxena BN
    Contraception; 1995 Mar; 51(3):155-65. PubMed ID: 7621684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing menstrual disturbances.
    Barnett B
    Netw Res Triangle Park N C; 1995 Jun; 15(4):8. PubMed ID: 12289833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron status in 268 Danish women aged 18-30 years: influence of menstruation, contraceptive method, and iron supplementation.
    Milman N; Clausen J; Byg KE
    Ann Hematol; 1998; 77(1-2):13-9. PubMed ID: 9760147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contraceptives for lactating women: a comparative trial of a progesterone-releasing vaginal ring and the copper T 380A IUD.
    Sivin I; Díaz S; Croxatto HB; Miranda P; Shaaban M; Sayed EH; Xiao B; Wu SC; Du M; Alvarez F; Brache V; Basnayake S; McCarthy T; Lacarra M; Mishell DR; Koetsawang S; Stern J; Jackanicz T
    Contraception; 1997 Apr; 55(4):225-32. PubMed ID: 9179454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Menstrual impact of contraception.
    Stubblefield PG
    Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1513-22. PubMed ID: 8178900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detailed analysis of menstrual bleeding patterns after postmenstrual and postabortal insertion of a copper IUD or a levonorgestrel-releasing intrauterine system.
    Suvisaari J; Lähteenmäki P
    Contraception; 1996 Oct; 54(4):201-8. PubMed ID: 8922872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuation rates of long-acting methods of contraception. A comparative study of Norplant implants and intrauterine devices.
    Fleming D; Davie J; Glasier A
    Contraception; 1998 Jan; 57(1):19-21. PubMed ID: 9554246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between experience of specific side-effects and contraceptive switching and discontinuation in Uganda: results from a longitudinal study.
    Zimmerman LA; Sarnak DO; Karp C; Wood SN; Ahmed S; Makumbi F; Kibira SPS
    Reprod Health; 2021 Nov; 18(1):239. PubMed ID: 34838097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can intrauterine device removals for bleeding or pain be predicted at a one-month follow-up visit? A multivariate analysis.
    Stanback J; Grimes D
    Contraception; 1998 Dec; 58(6):357-60. PubMed ID: 10095972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of Discontinuation of Long-Acting Reversible Contraception Before 30 Months of Use by Adolescents and Young Women.
    Cohen R; Sheeder J; Teal SB
    J Adolesc Health; 2019 Aug; 65(2):295-302. PubMed ID: 31196778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acceptability of the once-a-month injectable contraceptives Cyclofem and Mesigyna in Egypt.
    Hassan EO; el-Nahal N; el-Hussein M
    Contraception; 1994 May; 49(5):469-88. PubMed ID: 8045133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormonally impregnated intrauterine systems (IUSs), versus other forms of reversible contraceptives as effective methods of preventing pregnancy.
    French R; Cowan F; Mansour D; Morris S; Hughes D; Robinson A; Proctor T; Summerbell C; Logan S; Guillebaud J
    Cochrane Database Syst Rev; 2001; (2):CD001776. PubMed ID: 11406007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Menstrual bleeding expectations and short-term contraception discontinuation in Mexico.
    Zetina-Lozano G
    Stud Fam Plann; 1983 May; 14(5):127-33. PubMed ID: 6879617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Menstrual bleeding patterns in Norplant-2 implant users.
    Biswas A; Leong WP; Ratnam SS; Viegas OA
    Contraception; 1996 Aug; 54(2):91-5. PubMed ID: 8842585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.